VASODILATOR AND CONSTRICTOR ACTIONS OF PLATELET-ACTIVATING-FACTOR IN THE ISOLATED MICROPERFUSED AFFERENT ARTERIOLE OF THE RABBIT KIDNEY - ROLE OF ENDOTHELIUM-DERIVED RELAXING FACTOR NITRIC-OXIDE AND CYCLOOXYGENASE PRODUCTS
La. Juncos et al., VASODILATOR AND CONSTRICTOR ACTIONS OF PLATELET-ACTIVATING-FACTOR IN THE ISOLATED MICROPERFUSED AFFERENT ARTERIOLE OF THE RABBIT KIDNEY - ROLE OF ENDOTHELIUM-DERIVED RELAXING FACTOR NITRIC-OXIDE AND CYCLOOXYGENASE PRODUCTS, The Journal of clinical investigation, 91(4), 1993, pp. 1374-1379
It has been suggested that platelet-activating factor (PAF) plays a pr
ominent role in the control of glomerular hemodynamics in various phys
iological and pathological conditions. We examined the direct effect o
f PAF on rabbit glomerular afferent arterioles (Af-Arts) microperfused
in vitro and tested whether endothelium-derived relaxing factor/nitri
c oxide (EDNO) and cyclooxygenase products are involved in its actions
. In nanomolar concentrations PAF caused dose-dependent constriction o
f Af-Arts, with the maximum constriction being 34+/-10% at 4x10(-8) M
(n = 9, P < 0.001).The constriction was blunted by cyclooxygenase inhi
bition (11+/-6%, n = 7, P < 0.05) but augmented by EDNO inhibition (76
+/-14%, n = 8, P < 0.005). To study a possible vasodilator effect of P
AF, Af-Arts were preconstricted with norepinephrine and increasing con
centrations of PAF added to the lumen. At picomolar concentrations (lo
wer than those that caused constriction), PAF produced dose-dependent
vasodilation that was unaffected by cyclooxygenase inhibition but was
abolished by EDNO synthesis inhibition. Both PAF-induced constriction
and dilation of Af-Arts were blocked by a PAF receptor antagonist. Thi
s study demonstrates that PAF has a receptor-mediated biphasic effect
on rabbit Af-Arts, dilating them at low concentrations while constrict
ing them at higher concentrations. Our results suggest that PAF's vaso
dilator action may be due to production of EDNO, while its constrictor
action is mediated at least in part through cyclooxygenase products.